Cambridge Investment Research Advisors’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Sell
27,583
-21,300
-44% -$1.68M 0.01% 1581
2026
Q1
$3.39M Buy
48,883
+4,792
+11% +$346K 0.01% 1210
2025
Q4
$2.82M Sell
44,091
-655
-1% -$40.7K 0.01% 1257
2025
Q3
$2.67M Buy
44,746
+6,316
+16% +$397K 0.01% 1286
2025
Q2
$2.64M Sell
38,430
-2,783
-7% -$187K 0.01% 1220
2025
Q1
$2.54M Buy
41,213
+2,322
+6% +$127K 0.01% 1197
2024
Q4
$1.95M Buy
38,891
+15,042
+63% +$870K 0.01% 1375
2024
Q3
$1.58M Sell
23,849
-3,118
-12% -$192K 0.01% 1536
2024
Q2
$1.57M Sell
26,967
-7,899
-23% -$484K 0.01% 1460
2024
Q1
$2.12M Sell
34,866
-3,576
-9% -$224K 0.01% 1224
2023
Q4
$2.48M Buy
38,442
+87
+0.2% +$5.14K 0.01% 1061
2023
Q3
$2.12M Buy
38,355
+8,511
+29% +$482K 0.01% 1101
2023
Q2
$1.69M Sell
29,844
-10,578
-26% -$640K 0.01% 1274
2023
Q1
$2.7M Sell
40,422
-1,170
-3% -$70.7K 0.01% 964
2022
Q4
$2.5M Buy
41,592
+15,179
+57% +$815K 0.01% 963
2022
Q3
$1.19M Buy
26,413
+1,023
+4% +$53K 0.01% 1355
2022
Q2
$1.37M Sell
25,390
-2,302
-8% -$129K 0.01% 1248
2022
Q1
$1.66M Sell
27,692
-2,781
-9% -$171K 0.01% 1249
2021
Q4
$1.84M Sell
30,473
-9,335
-23% -$543K 0.01% 1197
2021
Q3
$2.24M Sell
39,808
-3,317
-8% -$208K 0.01% 1032
2021
Q2
$3.1M Sell
43,125
-603
-1% -$44K 0.01% 873
2021
Q1
$2.75M Sell
43,728
-13,031
-23% -$842K 0.01% 840
2020
Q4
$3.97M Buy
56,759
+17,984
+46% +$1.14M 0.02% 604
2020
Q3
$2.09M Sell
38,775
-976
-2% -$54.1K 0.01% 785
2020
Q2
$1.96M Buy
39,751
+23,663
+147% +$1.11M 0.01% 784
2020
Q1
$710K Buy
16,088
+1,869
+13% +$122K 0.01% 1159
2019
Q4
$1.17M Sell
14,219
-97
-0.7% -$8.08K 0.01% 1069
2019
Q3
$1.36M Sell
14,316
-1,732
-11% -$164K 0.01% 914
2019
Q2
$1.42M Sell
16,048
-1,057
-6% -$90.6K 0.01% 864
2019
Q1
$1.44M Buy
17,105
+1,931
+13% +$148K 0.01% 858
2018
Q4
$999K Buy
15,174
+3,042
+25% +$233K 0.01% 936
2018
Q3
$1.06M Sell
12,132
-545
-4% -$53.1K 0.01% 993
2018
Q2
$1.28M Buy
12,677
+2,594
+26% +$257K 0.01% 856
2018
Q1
$1.11M Buy
10,083
+88
+0.9% +$9.76K 0.01% 883
2017
Q4
$1.11M Sell
9,995
-205
-2% -$24.1K 0.01% 843
2017
Q3
$1.22M Buy
10,200
+375
+4% +$43.9K 0.02% 750
2017
Q2
$1.08M Sell
9,825
-989
-9% -$113K 0.02% 771
2017
Q1
$1.19M Buy
10,814
+3,898
+56% +$419K 0.02% 655
2016
Q4
$729K Buy
6,916
+1,932
+39% +$217K 0.01% 828
2016
Q3
$655K Buy
4,984
+121
+2% +$15.3K 0.01% 896
2016
Q2
$640K Sell
4,863
-1,152
-19% -$145K 0.01% 819
2016
Q1
$750K Buy
6,015
+83
+1% +$9.85K 0.02% 690
2015
Q4
$742K Sell
5,932
-1
-0% -$121 0.02% 671
2015
Q3
$631K Buy
5,933
+442
+8% +$51.3K 0.02% 655
2015
Q2
$663K Buy
5,491
+190
+4% +$23.3K 0.02% 675
2015
Q1
$646K Sell
5,301
-140
-3% -$16.9K 0.02% 676
2014
Q4
$611K Buy
5,441
+1,046
+24% +$116K 0.02% 676
2014
Q3
$487K Buy
4,395
+395
+10% +$44.1K 0.01% 844
2014
Q2
$460K Buy
4,000
+1,443
+56% +$159K 0.02% 796
2014
Q1
$269K Buy
2,557
+286
+13% +$29K 0.01% 1004
2013
Q4
$242K Buy
2,271
+251
+12% +$25.6K 0.01% 982
2013
Q3
$200K Sell
2,020
-281
-12% -$26.8K 0.01% 1046
2013
Q2
$208K Buy
+2,301
New +$219K 0.01% 937

Other funds holding BUD

Cambridge Investment Research Advisors's BUD Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its AB InBev (BUD) stake by 44% in Q2 2026, selling an estimated $1.68M and leaving 27,583 shares worth $2.27M. The position accounts for 0.01% of the portfolio, ranked #1581.

Cambridge Investment Research Advisors first reported a position in BUD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.97M in Q4 2020. 612 funds tracked by Wall St. Rank hold BUD as of Q2 2026.

  • Cambridge Investment Research Advisors held 27,583 shares of AB InBev worth $2.27M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 21,300 AB InBev shares in Q2 2026, an estimated $1.68M.
  • AB InBev made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1581 holding.
  • Cambridge Investment Research Advisors first reported a position in AB InBev in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's AB InBev position peaked at $3.97M in Q4 2020.
  • 612 funds tracked by Wall St. Rank held AB InBev as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.